Search

Your search keyword '"PHENYLPROPANOLAMINE"' showing total 93 results

Search Constraints

Start Over You searched for: Descriptor "PHENYLPROPANOLAMINE" Remove constraint Descriptor: "PHENYLPROPANOLAMINE" Publisher wiley Remove constraint Publisher: wiley
93 results on '"PHENYLPROPANOLAMINE"'

Search Results

1. Green synthesis of (S)-1-(furan-2-yl)propan-1-ol from asymmetric bioreduction of 1-(furan-2-yl)propan-1-one using whole-cell of Lactobacillus paracasei BD101.

2. Stereoselective Catalytic Synthesis of Active Pharmaceutical Ingredients in Homemade 3D-Printed Mesoreactors

3. Urethral Sphincter Mechanism Incompetence in 163 Neutered Female Dogs: Diagnosis, Treatment, and Relationship of Weight and Age at Neuter to Development of Disease

4. The Methylene Alkoxy Carbamate Self-Immolative Unit: Utilization for the Targeted Delivery of Alcohol-Containing Payloads with Antibody-Drug Conjugates

5. Evaluation of sulfated maltodextrin as a novel anionic chiral selector for the enantioseparation of basic chiral drugs by capillary electrophoresis

6. Separation and Determination of Cold Medicine Ingredients by Capillary Zone Electrophoresis Using Sulfated β-Cyclodextrin as an Electrolyte Modifier and Chiral Selector

7. Combination of foot stimulation and tolterodine treatment eliminates bladder overactivity in cats

8. Two Steps in One Pot: Enzyme Cascade for the Synthesis of Nor(pseudo)ephedrine from Inexpensive Starting Materials

9. ChemInform Abstract: Synthesis of BF3Catalyzed Mannich Derivatives with Excellent ee from Phenylpropanolamine, Study of Their Antimicrobial Activity and Molecular Docking

10. Evaluation of an experimental urodynamic platform to identify treatment effects: A randomized, placebo-controlled, crossover study in patients with overactive bladder

11. Transobturator Vaginal Tape Inside Out for Treatment of Urethral Sphincter Mechanism Incompetence: Preliminary Results in 7 Female Dogs

12. Effect of fluid management on fluid intake and urge incontinence in a trial for overactive bladder in women

13. A multicomponent behavioural and drug intervention for nocturia in elderly men: rationale and pilot results

14. Does urodynamic verification of overactive bladder determine treatment success? Results from a randomized placebo-controlled study

15. Roles of protein kinase Cα isozyme in the regulation of oxidative stress and neuropeptide Y gene expression in phenylpropanolamine-mediated appetite suppression

16. Cost-effectiveness analysis of solifenacin flexible dosing in patients with overactive bladder symptoms in four Nordic countries

17. Comparison of fesoterodine and tolterodine in patients with overactive bladder

18. Extended-release tolterodine with or without tamsulosin in men with lower urinary tract symptoms and overactive bladder: effects on urinary symptoms assessed by the International Prostate Symptom Score

19. Principles for different modes of multiple-injection CZE

20. Protracted ‘anti-addictive’ effects of adolescent phenylpropanolamine exposure in C57BL/6J mice

21. Transcriptional interruption of cAMP response element binding protein modulates superoxide dismutase and neuropeptide Y-mediated feeding behavior in freely moving rats

22. Evaluation of the Potential for Pharmacodynamic and Pharmacokinetic Drug Interactions Between Selegiline Transdermal System and Two Sympathomimetic Agents (Pseudoephedrine and Phenylpropanolamine) in Healthy Volunteers

23. Simultaneous chiral separation and determination of ephedrine alkaloids by MEKC-ESI-MS using polymeric surfactant I: Method development

24. Achieving continence with antimuscarinic therapy for overactive bladder: effects of baseline incontinence severity and bladder diary duration

25. The responsiveness of the OAB-q among OAB patient subgroups

26. A meta-analysis comparing trials of antimuscarinic medications funded by industry or not

27. Efficacy and tolerability of tolterodine extended-release in continent patients with overactive bladder and nocturia

28. Efficacy and tolerability of tolterodine extended-release in men with overactive bladder and urgency urinary incontinence

29. Intravesical instillation of human urine after oral administration of trospium, tolterodine and oxybutynin in a rat model of detrusor overactivity

30. Analysis of Phenylpropanolamine by Micellar Electroknetic Chromatography with Laser-induced Fluorescence Detection

31. Effect of the Proton Pump Inhibitor Omeprazole on the Pharmacokinetics of Extended-Release Formulations of Oxybutynin and Tolterodine

32. Application of dimethyl-β-cyclodextrin as a chiral selector in capillary electrophoresis for enantiomer separation of ephedrine and related compounds in some drugs

33. Determination of ephedrine and related compounds in pharmaceutical preparations by ion chromatography with direct conductivity detection

34. Comparison of doxazosin with or without tolterodine in men with symptomatic bladder outlet obstruction and an overactive bladder

35. Elimination of ephedrines in urine following multiple dosing: the consequences for athletes, in relation to doping control

36. Tolterodine is equally effective in patients with mixed incontinence and those with urge incontinence alone

37. Chiral characterization of deprenyl-N-oxide and other deprenyl metabolites by capillary electrophoresis using a dual cyclodextrin system in rat urine

38. Pharmacokinetics of cathinone, cathine and norephedrine after the chewing of khat leaves

39. Effects of ATP-sensitive K+ channel openers and tolterodine on involuntary bladder contractions in a pig model of partial bladder outlet obstruction

40. Treatment of urethral sphincter mechanism incompetence in 11 bitches with a sustainedrelease formulation of phenylpropanolamine hydrochloride

42. Tolterodine: As effective but better tolerated than oxybutynin in Asian patients with symptoms of overactive bladder

43. HPLC determination of phenylpropanolamine in pharmaceutical OTC preparations

44. A Novel Mixed Dimer of a Norephedrine-Derived Chiral Lithium Amide and 2-Lithium-1-methylimidazole, and Catalytic Enantioselective Deprotonation of Cyclohexene Oxide

45. Tolterodine: A Safe and Effective Treatment for Older Patients with Overactive Bladder

46. Effects of Tolterodine, Trospium Chloride, and Oxybutynin on the Central Nervous System

47. Influence of a combination of herbs on appetite suppression and weight loss in rats

48. MUSCARINIC RECEPTOR ANTAGONISTS IN THE TREATMENT OF OVERACTIVE BLADDER

49. Immediate-Release Oxybutynin versus Tolterodine in Detrusor Overactivity: A Population Analysis

50. Serum protein binding of tolterodine and its major metabolites in humans and several animal species

Catalog

Books, media, physical & digital resources